|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.83 USD | +1.31% |
|
+9.22% | +16.58% |
| 06-18 | Barclays Initiates Indivior at Overweight With $46 Price Target | MT |
| 06-10 | Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 45.05 | 47.99 | 49.46 |
| Spread/Res. | -7.15% | -12.84% | -15.43% |
| Spread/Supp. | +10.28% | +24.09% | +44.39% |
| Support | 37.93 | 33.71 | 28.97 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- INDV Stock
- Charts Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
